Marc Semigran insider trades

Open-market stock purchases and sales by Marc Semigran, Chief Development Officer at Edgewise Therapeutics, Inc, from SEC Form 4 filings since Dec 1, 2016.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • EWTX Edgewise Therapeutics, Inc: 2 sales, last Dec 24, 2024
  • RCOR Renovacor, Inc: other filings, last Dec 1, 2022
  • MYOK MyoKardia Inc: 2 sales, last Oct 31, 2018

Get free alerts when Marc Semigran files a new trade →